Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice

Neurosci Res. 2009 Jan;63(1):72-5. doi: 10.1016/j.neures.2008.09.009. Epub 2008 Oct 14.

Abstract

We evaluated the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57BL/6N mice fed a magnesium (Mg(2+))-deficient diet. On the 3rd week, Mg(2+)-deficient mice displayed increased anxiety- and depression-like behavior. In the Mg(2+)-deficient mice, a low does (10mg/kg) of MPTP treatment decreased dopamine (DA) and its metabolites contents in the striatum, but not in control mice. The same dose of MPTP did not influence these neurochemical markers in the mice fed Mg(2+)-deficient diet for 1 week which did not exhibit the altered emotional behavior. These results indicate that Mg(2+)-deficient mice with altered emotional behavior appear to increase the susceptibility to MPTP neurotoxicity in C57BL/6N mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology
  • Animals
  • Causality
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Corpus Striatum / physiopathology
  • Disease Models, Animal
  • Dopamine / metabolism*
  • Dopamine Agents / pharmacology
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects
  • Down-Regulation / physiology
  • Emotions / drug effects
  • Emotions / physiology
  • Magnesium / metabolism*
  • Magnesium Deficiency / complications
  • Magnesium Deficiency / metabolism*
  • Magnesium Deficiency / physiopathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Parkinsonian Disorders / etiology
  • Parkinsonian Disorders / metabolism*
  • Parkinsonian Disorders / physiopathology
  • Substantia Nigra / drug effects
  • Substantia Nigra / metabolism
  • Substantia Nigra / physiopathology

Substances

  • Dopamine Agents
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Magnesium
  • Dopamine